Rongsen Meng

468 total citations
15 papers, 377 citations indexed

About

Rongsen Meng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Rongsen Meng has authored 15 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Rongsen Meng's work include Metabolism, Diabetes, and Cancer (4 papers), Adipose Tissue and Metabolism (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Rongsen Meng is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Adipose Tissue and Metabolism (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Rongsen Meng collaborates with scholars based in China and United States. Rongsen Meng's co-authors include Baolin Chen, Yugang Dong, Zhaohui Pei, Aixia Zhang, Yuedong Ma, Zhaojun Xiong, Zhiqiang Zhuang, Jun Ren, Zhenbiao Wu and Fengjuan Yao and has published in prestigious journals such as Archives of Biochemistry and Biophysics, European Journal of Pharmacology and Pharmacological Research.

In The Last Decade

Rongsen Meng

15 papers receiving 369 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rongsen Meng	210	149	76	60	53	15	377
Christophe Beauloye	246 1.2×	152 1.0×	62 0.8×	79 1.3×	60 1.1×	8	392
Teresa Chen	175 0.8×	132 0.9×	56 0.7×	48 0.8×	44 0.8×	10	381
Timothy D. Calamaras	220 1.0×	240 1.6×	110 1.4×	46 0.8×	35 0.7×	16	454
Anzhi Dai	332 1.6×	156 1.0×	106 1.4×	56 0.9×	80 1.5×	10	477
Ke‐Xue Li	207 1.0×	95 0.6×	63 0.8×	47 0.8×	43 0.8×	17	465
Wenjuan Liu	215 1.0×	148 1.0×	30 0.4×	36 0.6×	31 0.6×	21	389
Tenley A. Rawlings	224 1.1×	199 1.3×	116 1.5×	81 1.4×	47 0.9×	8	394
Giselle Barreto‐Torres	303 1.4×	184 1.2×	58 0.8×	47 0.8×	28 0.5×	9	434
Dor Yadin	205 1.0×	204 1.4×	89 1.2×	69 1.1×	107 2.0×	11	417
Yanzhen Tan	198 0.9×	169 1.1×	159 2.1×	52 0.9×	53 1.0×	23	529

Countries citing papers authored by Rongsen Meng

Since Specialization

Citations

This map shows the geographic impact of Rongsen Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongsen Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongsen Meng more than expected).

Fields of papers citing papers by Rongsen Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongsen Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongsen Meng. The network helps show where Rongsen Meng may publish in the future.

Co-authorship network of co-authors of Rongsen Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Rongsen Meng. A scholar is included among the top collaborators of Rongsen Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongsen Meng. Rongsen Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Meng, Rongsen, et al.. (2023). The risk of all-cause death with dapagliflozin versus placebo: a systematic review and meta-analysis of phase III randomized controlled trials. Expert Opinion on Drug Safety. 22(2). 133–140. 1 indexed citations

Meng, Rongsen, et al.. (2023). Indirect Comparison of SGLT2 Inhibitors in Patients with Established Heart Failure: Evidence Based on Bayesian Methods. ESC Heart Failure. 10(2). 1231–1241. 8 indexed citations

Meng, Rongsen, et al.. (2021). miR‑454‑3p prevents ox‑LDL‑induced apoptosis in HAECs by targeting TRPC3. Experimental and Therapeutic Medicine. 21(4). 323–323. 4 indexed citations

Pei, Zhaohui, Zhiqiang Zhuang, Hanfei Sang, et al.. (2014). α,β-Unsaturated aldehyde crotonaldehyde triggers cardiomyocyte contractile dysfunction: Role of TRPV1 and mitochondrial function. Pharmacological Research. 82. 40–50. 34 indexed citations

Pei, Zhaohui, Rongsen Meng, Zhiqiang Zhuang, et al.. (2013). Cardiac Peroxisome Proliferator-Activated Receptor-γ Expression is Modulated by Oxidative Stress in Acutely Infrasound-Exposed Cardiomyocytes. Cardiovascular Toxicology. 13(4). 307–315. 10 indexed citations

Meng, Rongsen, Zhaohui Pei, Aixia Zhang, et al.. (2011). AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway. Archives of Biochemistry and Biophysics. 511(1-2). 1–7. 66 indexed citations

Chen, Baolin, Zhaojun Xiong, Yuedong Ma, et al.. (2010). [Effects of AMPK on the transcriptional activity of FOXO1 and ubiquitin ligase MuRF1 expression in rat cardiomyocytes].. PubMed. 30(11). 2419–22. 1 indexed citations

Meng, Rongsen, et al.. (2010). Metformin attenuates ventricular hypertrophy by activating the AMP‐activated protein kinase–endothelial nitric oxide synthase pathway in rats. Clinical and Experimental Pharmacology and Physiology. 38(1). 55–62. 72 indexed citations

Chen, Baolin, Yuedong Ma, Rongsen Meng, et al.. (2010). Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro. Acta Pharmacologica Sinica. 31(7). 798–804. 45 indexed citations

10.

Chen, Baolin, Yuedong Ma, Rongsen Meng, et al.. (2010). MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals. Acta Biochimica et Biophysica Sinica. 42(4). 253–258. 32 indexed citations

11.

Pei, Zhaohui, Rongsen Meng, Guangwei Li, et al.. (2010). Angiotensin-(1–7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: Role of MMPs/TIMPs. Toxicology Letters. 199(2). 173–181. 34 indexed citations

12.

Meng, Rongsen, Zhaohui Pei, Ran Yin, et al.. (2009). Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-α signaling pathway. European Journal of Pharmacology. 620(1-3). 63–70. 40 indexed citations

13.

Meng, Rongsen, Zhaohui Pei, Bo Chen, et al.. (2009). Age-related change of serum angiogenic factor levels in patients with coronary artery disease. Acta Cardiologica. 64(6). 735–740. 9 indexed citations

14.

He, Jiangui, Yili Chen, Fengjuan Yao, et al.. (2008). Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats. European Journal of Pharmacology. 602(1). 132–137. 17 indexed citations

15.

Meng, Rongsen, et al.. (2005). Clinical observation and mechanism study on treatment of senile dementia with Naohuandan. Chinese Journal of Integrative Medicine. 11(2). 111–116. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact